Supernus Pharmaceuticals Inc (SUPN)

Inventory turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	401,888	0	467,442	382,420	257,436
Inventory	US$ in thousands	54,293	77,408	91,541	85,959	48,325
Inventory turnover		7.40	0.00	5.11	4.45	5.33

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $401,888K ÷ $54,293K
= 7.40

Supernus Pharmaceuticals Inc's inventory turnover has shown some fluctuation over the years. The ratio was at 5.33 times in December 31, 2020, indicating that the company sold and replaced its inventory approximately 5.33 times during that year. However, there was a decrease in inventory turnover to 4.45 times as of December 31, 2021, which may suggest a slower movement of inventory or potential issues managing stock levels.

Subsequently, the inventory turnover improved to 5.11 times by December 31, 2022, indicating a more efficient management of inventory during that period. However, there seems to be a significant anomaly in the data with an inventory turnover of 0.00 times on December 31, 2023, which is unusual and may require further investigation to understand the reasons behind such a drastic change.

Finally, the inventory turnover ratio increased dramatically to 7.40 times as of December 31, 2024, suggesting that Supernus Pharmaceuticals Inc was able to sell and replace its inventory more quickly during that year, potentially indicating effective inventory management strategies.

Overall, the company's inventory turnover has shown varying trends over the years, with some fluctuations that may require a closer look into the underlying reasons for these changes to assess the effectiveness of the company's inventory management practices.